GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

OpenAI have announced the early release of its new AI-powered life sciences application GPT-Rosalind to specific life science groups.

OpenAI sees three top executives leave on the same day. This follows the company's decision to close experimental projects ...

LLMs were tested across 29 clinical scenarios, generating a total of 16,254 responses. The PrIME-LLM scores ranged from 0.64 ...

Still, that doesn't change the fact that the stock has considerable potential if and when it starts to scale a commercial ...

SunFounder has sent us a sample of the Pironman 5 Pro Max tower PC case for Raspberry Pi 5 for review alongside a PiPower 5 ...

TSMC (TSM) beat Q1 results with record margins; see why AI demand, advanced nodes and a 19x P/E support a $430 target (25% ...

During the years I worked for the Manitoba government, I had a hand in writing several of the premier’s “state of the ...